Skip to main content

Saint Louis University Header Logo Center

Menu Search

William S. Sly Lecture: 'Experiences in Research at Merck and Their Impact on World Health'

Monday, 13 November, 2017

The Department of Biochemistry and Molecular Biology and School of Medicine will present the third William S. Sly Lecture featuring P. Roy Vagelos, M.D., from 4 to 6 p.m. on Monday, Nov. 13, in the Health Education Union.

Vagelos served as chairman of biochemistry at Washington University for eight years become becoming Merck’s head of research. He went on to become CEO of Merck and was named as Fortune Magazine’s Executive of the Year for seven consecutive years.

Following his retirement from Merck, Vagelos served as chairman of the Board of the University of Pennsylvania, his alma mater, until becoming chairman of the board for Regeneron Pharmaceutical, his current position, at age 70.

Vagelos and his wife, Diana, are major philanthropists, giving substantial gifts to a number of institutions, including Columbia University, where Vagelos received his medical degree in 1956.

The William S. Sly Lecture honors pioneering SLU researcher William S. Sly, M.D., and is part of the University’s bicentennial events.